158 related articles for article (PubMed ID: 34631744)
1. Exhaled Volatile Organic Compounds for Identifying Patients With Chronic Pulmonary Aspergillosis.
Li ZT; Zeng PY; Chen ZM; Guan WJ; Wang T; Lin Y; Li SQ; Zhang ZJ; Zhan YQ; Wang MD; Tan GB; Li X; Ye F
Front Med (Lausanne); 2021; 8():720119. PubMed ID: 34631744
[No Abstract] [Full Text] [Related]
2. Potential value of serum Aspergillus IgG antibody detection in the diagnosis of invasive and chronic pulmonary aspergillosis in non-agranulocytic patients.
Yu Q; He J; Xing B; Li X; Qian H; Zhang H; Xu M; Peng H
BMC Pulm Med; 2020 Apr; 20(1):89. PubMed ID: 32293386
[TBL] [Abstract][Full Text] [Related]
3. A breath fungal secondary metabolite signature to diagnose invasive aspergillosis.
Koo S; Thomas HR; Daniels SD; Lynch RC; Fortier SM; Shea MM; Rearden P; Comolli JC; Baden LR; Marty FM
Clin Infect Dis; 2014 Dec; 59(12):1733-40. PubMed ID: 25342502
[TBL] [Abstract][Full Text] [Related]
4. Role of the
Li H; Rui Y; Zhou W; Liu L; He B; Shi Y; Su X
Front Microbiol; 2019; 10():1438. PubMed ID: 31316486
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances in Diagnosing Chronic Pulmonary Aspergillosis.
Takazono T; Izumikawa K
Front Microbiol; 2018; 9():1810. PubMed ID: 30174658
[No Abstract] [Full Text] [Related]
6. Metabolomic profiling of exhaled breath condensate for the diagnosis of pulmonary aspergillosis.
Wei S; Chen YS; Shi Y
Front Cell Infect Microbiol; 2022; 12():1008924. PubMed ID: 36159648
[TBL] [Abstract][Full Text] [Related]
7. Profiling of volatile organic compounds produced by clinical Aspergillus isolates using gas chromatography-mass spectrometry.
Gerritsen MG; Brinkman P; Escobar N; Bos LD; de Heer K; Meijer M; Janssen HG; de Cock H; Wösten HAB; Visser CE; van Oers MHJ; Sterk PJ
Med Mycol; 2018 Feb; 56(2):253-256. PubMed ID: 28525576
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of LDBio
Stucky Hunter E; Richardson MD; Denning DW
J Clin Microbiol; 2019 Sep; 57(9):. PubMed ID: 31217272
[TBL] [Abstract][Full Text] [Related]
9. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R
J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966
[TBL] [Abstract][Full Text] [Related]
10.
Jabeen K; Farooqi J; Iqbal N; Wahab K; Irfan M
J Fungi (Basel); 2020 Oct; 6(4):. PubMed ID: 33114653
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic cut-off value for Aspergillus fumigatus- and flavus-specific IgG with clinical relevance in chronic pulmonary Aspergillus infection: A pilot study in Taiwan.
Huang SF; Li SY; Chan YJ; Huang YC; Yang YY; Wang FD
Mycoses; 2020 Oct; 63(10):1083-1093. PubMed ID: 32677131
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of
Takazono T; Ito Y; Tashiro M; Nishimura K; Saijo T; Yamamoto K; Imamura Y; Miyazaki T; Yanagihara K; Mukae H; Izumikawa K
J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30842231
[TBL] [Abstract][Full Text] [Related]
13. Establishing Aspergillus-Specific IgG Cut-Off Level for Chronic Pulmonary Aspergillosis Diagnosis: Multicenter Prospective Cohort Study.
Lee MR; Huang HL; Keng LT; Chang HL; Sheu CC; Fu PK; Wang JY; Chong IW; Shih JY; Yu CJ
J Fungi (Basel); 2021 Jun; 7(6):. PubMed ID: 34204844
[TBL] [Abstract][Full Text] [Related]
14. High detection rate of azole-resistant Aspergillus fumigatus after treatment with azole antifungal drugs among patients with chronic pulmonary aspergillosis in a single hospital setting with low azole resistance.
Takeda K; Suzuki J; Watanabe A; Arai T; Koiwa T; Shinfuku K; Narumoto O; Kawashima M; Fukami T; Tamura A; Nagai H; Matsui H; Kamei K
Med Mycol; 2021 Apr; 59(4):327-334. PubMed ID: 32642756
[TBL] [Abstract][Full Text] [Related]
15. Analysis of human breath samples using a modified thermal desorption: gas chromatography electrospray ionization interface.
Reynolds JC; Jimoh MA; Guallar-Hoyas C; Creaser CS; Siddiqui S; Paul Thomas CL
J Breath Res; 2014 Sep; 8(3):037105. PubMed ID: 25190194
[TBL] [Abstract][Full Text] [Related]
16. Siemens Immulite Aspergillus-specific IgG assay for chronic pulmonary aspergillosis diagnosis.
Page ID; Richardson MD; Denning DW
Med Mycol; 2019 Apr; 57(3):300-307. PubMed ID: 29762749
[TBL] [Abstract][Full Text] [Related]
17. Volatile Organic Compounds in Exhaled Breath of Idiopathic Pulmonary Fibrosis for Discrimination from Healthy Subjects.
Yamada YI; Yamada G; Otsuka M; Nishikiori H; Ikeda K; Umeda Y; Ohnishi H; Kuronuma K; Chiba H; Baumbach JI; Takahashi H
Lung; 2017 Apr; 195(2):247-254. PubMed ID: 28247041
[TBL] [Abstract][Full Text] [Related]
18. Effects of Curative Colorectal Cancer Surgery on Exhaled Volatile Organic Compounds and Potential Implications in Clinical Follow-up.
Altomare DF; Di Lena M; Porcelli F; Travaglio E; Longobardi F; Tutino M; Depalma N; Tedesco G; Sardaro A; Memeo R; de Gennaro G
Ann Surg; 2015 Nov; 262(5):862-6; discussion 866-7. PubMed ID: 26583677
[TBL] [Abstract][Full Text] [Related]
19. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
[TBL] [Abstract][Full Text] [Related]
20. Study of 5 Volatile Organic Compounds in Exhaled Breath in Chronic Obstructive Pulmonary Disease.
Jareño-Esteban JJ; Muñoz-Lucas MÁ; Gómez-Martín Ó; Utrilla-Trigo S; Gutiérrez-Ortega C; Aguilar-Ros A; Collado-Yurrita L; Callol-Sánchez LM
Arch Bronconeumol; 2017 May; 53(5):251-256. PubMed ID: 27780574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
